St. Louis founders can build a focused funding plan across software, financial technology, life sciences and agriculture. This guide compares nine direct venture or angel-capital providers, including one strategic healthcare growth route and Missouri’s statewide co-investment program. It also labels an investment accelerator and Arch Grants separately. Start with the company milestone and customer evidence, then select the providers whose actual criteria match your next round.
Compare the funding routes
| Organization | Type | Office or investment connection | Published focus and founder route |
|---|---|---|---|
| Cultivation Capital | Venture firm | St. Louis office; broader investments | Seed through Series B across software, health, agriculture and geospatial strategies; contact the relevant team |
| SixThirty | Early-stage venture firm | Clayton, St. Louis metro; global investing | Health, wealth and privacy; The Canvas founder submission |
| Lewis & Clark Ventures | Early-stage venture firm | St. Louis office | Late Seed through Series A B2B software; company contact |
| BioGenerator | Bioscience venture investor and company builder | St. Louis investment focus | Human health and agriculture; commercialization/investment inquiry |
| RiverVest | Life-science venture firm | St. Louis and other offices | Biopharma and medical devices; investment-team contact |
| Ascend Venture Capital | Data-centric technology venture firm | St. Louis, according to its company profile | Mission-critical technology and active prototypes; company appointment form |
| St. Louis Arch Angels | Angel-investor network | St. Louis regional ecosystem | High-growth seed and early-stage businesses; invitation/screening process |
| Missouri Technology Corporation | Statewide public-private co-investment program | Missouri-headquartered company requirement | Pre-seed through later venture stages by program; IDEA application portal |
| Ascension Ventures | Strategic healthcare venture and growth investor | St. Louis office; broader investing | Healthcare IT/services, devices and diagnostics; business-plan contact |
Research note: First-party materials were reviewed on October 14, 2026. This selected directory is not a ranking. Offices, investment mandates and program types are labeled separately. Vehicles are counted once under their manager; review current founder instructions and program cycles before applying.
Cultivation Capital
Cultivation Capital has a St. Louis office and several distinct investment strategies. Its current overview describes Seed-through-Series-B investing across software and IT, life sciences and health technology, agriculture, Midwest seed and geospatial technology. Those strategies are not interchangeable. Identify the team whose customer and technology thesis fits the company, then prepare the current milestone and evidence for that conversation. Use its company contact information and explain the relevant strategy instead of sending an undifferentiated deck to every fund vehicle.
SixThirty
SixThirty is based in the St. Louis metropolitan area and invests globally in early-stage companies at the intersection of health, wealth and privacy. Its current positioning includes fintech, insurtech, digital health and enterprise collaboration. A useful pitch explains the actual institutional buyer or collaborator and why the product belongs at that intersection. The contact page directs founders to The Canvas as the first step. Use that founder submission rather than the general-inquiry form, and prepare company evidence without assuming investment brings an automatic customer partnership.
Lewis & Clark Ventures
Lewis & Clark Ventures has a St. Louis office and a clear late-Seed-through-Series-A B2B software focus. Its investment criteria emphasize ambitious founders and a team capable of building the company. That stage range is a useful filter for businesses moving from initial product proof toward a larger commercial operation. Prepare customer evidence, the go-to-market story and what the round would enable. Use the company contact route to discuss fit, rather than assuming every software idea matches the firm’s current stage.
BioGenerator
BioGenerator is BioSTL’s startup arm, creating, building and investing in St. Louis companies addressing human-health and agricultural challenges. The current BioSTL overview distinguishes investment, company-building support, laboratory resources and grant-supported concepts. Keep those offerings under one organization record and identify which route the company needs. A bioscience founder can start with the research, development milestone and proposed St. Louis operating connection. Use BioSTL/BioGenerator’s public inquiry route to ask about investment or commercialization fit instead of treating every lab client as a funded portfolio company.
RiverVest
RiverVest’s St. Louis office is part of a life-science venture firm with other locations, including Cleveland and San Diego. Its approach centers on biopharma and medical devices addressing unmet patient needs, including company formation and scientific development. Prepare the product’s clinical rationale, development evidence and next scientific milestone. This is a specialist route, not a general enterprise-software target. Use the investment team’s public contact information to clarify the applicable strategy, without counting every RiverVest fund or seed vehicle as another independent investor.
Ascend Venture Capital
Ascend’s company profile identifies its St. Louis headquarters, while its official website describes data-centric companies building mission-critical technology. Its public criteria include an active prototype, substantial growth potential and milestone-based investing. Prepare an explanation of what the prototype proves, which workflow or industry it changes and the next milestone. The contact page provides an appointment inquiry. Keep this St. Louis firm separate from the unrelated Seattle investor using the Ascend name, and do not infer a fixed check size or universal stage from directory listings.
St. Louis Arch Angels
St. Louis Arch Angels provides seed and early-stage capital through a member network. Its published criteria emphasize high-growth potential and a formal screening process examining the team, business plan, market and intellectual property. The pitching process describes an invitation-based application and screening before member presentations. Begin with the designated contact to request consideration, then prepare the requested materials. This is not the Become an Angel membership path, and a presentation invitation should not be recorded as a funding commitment.
Missouri Technology Corporation
Missouri Technology Corporation’s IDEA Fund is a statewide co-investment program, not a St. Louis-only private fund or a generic grant. It invests through equity or convertible debt, with different programs spanning pre-seed, seed and later venture rounds. Current requirements include Missouri headquarters, qualifying business criteria and matching private investment. Review the program FAQs and application portal for the applicable round. Track the matching investor, timing and program decision separately; do not make your own eligibility determination from this directory.
Ascension Ventures
Ascension Ventures has a St. Louis office and invests strategically in healthcare information technology, services, medical devices and diagnostics. Its criteria cover venture and growth equity, with established teams, adoption potential and early-to-late-stage companies approaching a potential liquidity event. Keep it in a strategic healthcare or growth lane, not a generic first-check pre-seed list. Prepare the business plan and evidence of clinical or operational value to health systems. Its contact page supplies the designated route for healthcare investment opportunities.
Investment accelerator and equity-free funding
Capital Innovators
Capital Innovators combines venture investment with a St. Louis startup accelerator. Its current overview describes Seed and Series A investments in technology and consumer products, while the accelerator page lists seed funding, mentorship and company-building resources. Count the manager once and record whether you are exploring a direct venture or cohort-based path. Different corporate programs can have different funding structures, so use the relevant program instructions. Confirm the current application cycle and participation terms before preparing an accelerator submission.
Arch Grants
Arch Grants offers a separate, equity-free startup funding competition tied to building a business in St. Louis. Its current competition page describes the company-location commitments and confirms that applications for the 2026 competition are closed. Treat it as a future competition-research route, not an immediately open VC application. Prepare the company’s proposed operating plan and review the next cycle’s criteria when released. Keep the grant workstream separate from venture terms, investment screening and accelerator participation, even when the same founder manages all three.
Connect the company milestone to the funding route
Use this worksheet to turn the comparison into a focused research plan. Keep the source beside each answer so your team can revisit it when a strategy changes.
| Check | Evidence to collect | What to do with it |
|---|---|---|
| Strategy | Software, health, agriculture, geospatial or another stated theme | Identify the relevant team inside a manager |
| Customer | Who adopts or buys the product | Explain why the target’s thesis fits |
| Founder route | Company contact, invitation process or SixThirty’s Canvas | Prepare the correct requested materials |
| Co-investment | Missouri company conditions, matching investor and program timing | Keep MTC’s process separate from the lead-investor conversation |
| Competition | Next Arch Grants cycle and company commitments | Maintain a separate competition checklist |
| Accelerator | Investment path, cohort and participation terms | Do not conflate seed funding with a grant-based corporate program |
| Milestone | What the company has proven and what remains | Avoid treating application progress as funding |
Worked example (fictional): A St. Louis health-software company prepares a customer brief for venture conversations. Another row records the next Arch Grants cycle and operating commitments; a third checks whether the round’s private investors can support an MTC application. The same team owns the workstreams, but the submission, decision and capital type remain separate. The founder can compare preparation priorities without mislabeling a grant competition or co-investment program as a conventional VC fund.
Keep the shortlist moving in Finta
Use Finta CRM to keep investor relationships, source links and next steps together. Give Aurora your company brief and the sources you have collected, then ask for a fit summary, open questions and a draft introduction to review. Keep uncertain facts as questions and choose what to send yourself.
Continue with our guide to finding startup investors, use the startup one-pager template to prepare your introduction, and organize the next conversations with a fundraising pipeline review.